Welcome to our dedicated page for Palatin Tech SEC filings (Ticker: PTN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Palatin Technologies filings document regulatory disclosures for a biopharmaceutical company developing melanocortin receptor-targeted drug candidates. Its 8-K reports and proxy materials cover capital-structure actions, including a 1-for-50 reverse stock split, warrant-share issuance approvals, equity incentive plan matters and listing or trading-status notices for the company’s common stock.
The filing record also includes material-event disclosure on a research collaboration, license and patent assignment agreement with Boehringer Ingelheim for retinal disease programs, annual meeting voting results, advisory executive-compensation votes, corporate governance matters, operating and financial results, and clinical or regulatory disclosures tied to Palatin’s development pipeline.
Palatin Technologies, Inc. reported insider equity tax-withholding transactions by an executive vice president and CFO/COO. On December 30, 2025, the officer had small amounts of common stock withheld by the company to cover employee withholding taxes tied to previously vested equity grants.
The filing shows three transactions coded "F" at a per-share value of $21.38, withholding 26, 91, and 95 shares from grants of 95, 330, and 345 shares that vested on December 8, 2025. After these tax-related withholdings, the officer reported beneficial ownership of 63,462, 63,371, and 63,276 shares of Palatin common stock in successive entries, all held directly.
Palatin Technologies, Inc. insider Carl Spana, who serves as President, CEO, and director, reported routine tax-related share withholding transactions. On December 30, 2025, the company withheld 40, 138, and 143 shares of common stock, all coded as transaction type “F,” to cover employee withholding taxes tied to previously vested equity awards. The per-share value used for these tax withholdings was $21.38, determined as of December 8, 2025, the vesting date of the underlying grants. After these transactions, Spana directly beneficially owned 64,377 shares of Palatin common stock.
Palatin Technologies, Inc. executive vice president and CFO/COO Stephen T. Wills reported a small sale of company stock. On 12/24/2025, he sold 565 shares of Palatin common stock at a price of $16.7443 per share, in a transaction described as being for estate planning purposes. After this sale, he beneficially owned 63,488 shares, held directly.
A holder of PTN common stock filed a Rule 144 notice to sell 565 shares through Charles Schwab on or about 12/24/2025 on the NYSE Amex. The aggregate market value for these shares is reported as $9,460.53, while total common shares outstanding are listed as 1,702,675. The shares to be sold were originally acquired on 03/04/2011 as stock grants from the issuer as equity compensation, with full payment made in the form of equity compensation on the same date.
Palatin Technologies, Inc. filed an amended current report to update the outcome of a governance-related item from its 2025 annual stockholder meeting. Stockholders voted, on an advisory and non-binding basis, to hold future advisory votes on executive compensation every year, consistent with the Board of Directors’ recommendation.
In response, the Board has decided to include an annual advisory vote on the compensation of the company’s named executive officers in its proxy materials each year, until the next required stockholder vote on how often these advisory votes should occur.
Palatin Technologies executive Stephen T. Wills, who serves as Executive VP and CFO/COO, reported the vesting of performance-based equity awards on December 9, 2025 under the company’s 2011 Stock Incentive Plan. He acquired 95, 330, and 345 restricted share units of common stock at a price of $0 per share as certain performance conditions were certified by the Compensation Committee. These restricted share units each represent the right to receive one share of common stock, with the shares to be issued on or before the 60th day following December 9, 2025.
On the same date, Wills also acquired performance-based stock options to buy Palatin common stock: 142 options with a $362.5 exercise price expiring on June 22, 2032, 518 options with a $109.5 exercise price expiring on June 20, 2033, and 495 options with a $91.5 exercise price expiring on June 4, 2034. Following these transactions, he directly beneficially owned 64,053 shares of common stock and 122,913 derivative securities in the form of stock options.
Palatin Technologies, Inc. director equity grant disclosure: A Palatin Technologies director reported receiving two stock option grants on December 9, 2025 under the company’s 2011 Stock Incentive Plan. Each option is a right to buy 2,400 shares of common stock at an exercise price of $21.38 per share, with both grants expiring on December 9, 2035.
One option grant vests on December 9, 2026, but if the director does not serve through December 31, 2026, it is prorated at 1/12 per month from January 31, 2026. The second option grant vests as to 50% on December 9, 2026 and the remaining 50% on December 9, 2027. Following these grants, the director beneficially owns 5,927 derivative securities in the form of stock options, all held directly.
Palatin Technologies, Inc. reported equity compensation changes for its President and CEO, who is also a director, in a Form 4 insider filing. On December 9, 2025, several performance-based restricted stock unit (RSU) awards granted under the 2011 Stock Incentive Plan partially vested after the Compensation Committee certified that a defined performance objective for the 18 months ending December 31, 2025 was achieved at 100% of the target level.
The vesting resulted in accruals of 110, 380, and 395 common shares at a stated price of $0 per share, bringing the reporting person’s beneficial ownership of common stock to 64,698 shares. The company states these shares have not yet been issued but will be delivered on or before the 60th day following December 9, 2025.
On the same date, three tranches of performance-based stock options also vested in part: 163 options at an exercise price of $362.5, 595 options at $109.5, and 568 options at $91.5, each for common stock, with expirations ranging from June 22, 2032 to June 4, 2034. Following these transactions, the reporting person held 123,939 stock options in total.
Palatin Technologies reported a director equity grant for John K.A. Prendergast. On December 9, 2025, he received 2,600 restricted stock units under the 2011 Stock Incentive Plan, split into two grants of 1,300 units each. One grant vests fully on December 9, 2026, and the other vests 50% on December 9, 2026 and 50% on December 9, 2027, each unit representing one share of common stock at no purchase price.
He was also granted 3,200 stock options at an exercise price of $21.38 per share in two blocks of 1,600 options, both expiring on December 9, 2035. One option grant vests on December 9, 2026 with potential monthly proration if service ends before December 31, 2026, while the other vests 50% on December 9, 2026 and 50% on December 9, 2027. Following these transactions, he beneficially owned 15,102 shares of common stock and 27,281 stock options directly.
Palatin Technologies, Inc. reported equity awards to a director in the form of restricted stock units and stock options under its 2011 Stock Incentive Plan. On December 9, 2025, the director received two grants of 1,000 restricted stock units each, at a price of $0 per share, increasing common stock holdings to 14,081 shares held directly after these awards.
The first restricted stock unit grant vests in full on December 9, 2026. The second vests 50% on December 9, 2026 and 50% on December 9, 2027. On the same date, the director was also granted two stock option awards covering 1,200 shares each at an exercise price of $21.38 per share. One option grant vests on December 9, 2026 with proration if board service ends before December 31, 2026, and the other vests 50% on December 9, 2026 and 50% on December 9, 2027.